×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| KOPRAN LTD. | 531.32 | 35.18 | 513.35 | 0.73 | 889.0 | 25.4 |
| NGL FINE-CHEM LTD. | 1074.12 | 76.44 | 1008.58 | 12.37 | 879 | 42.1 |
| WANBURY LTD. | 1635.32 | 134.91 | 1631.84 | 3.95 | 875 | 20.3 |
Kopran Ltd.,, with Security Code 524280, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 80.2 | 65.9 | 98.6 | 82.3 | 90.6 | 49.6 | 73.5 | 71.9 | 75.9 | 51.3 |
| Expenses | 72.9 | 63.7 | 89.9 | 70.3 | 75.3 | 44.3 | 63.8 | 60.5 | 63.6 | 46.3 |
| Operating Profit | 7.4 | 2.1 | 8.7 | 12.1 | 15.3 | 5.3 | 9.7 | 11.4 | 12.3 | 5.1 |
| OPM % | 9.18% | 3.23% | 8.82% | 14.65% | 16.93% | 10.65% | 13.18% | 15.85% | 16.24% | 9.88% |
| Other Income | 2.1 | 0.2 | 5.8 | 1.3 | 8.1 | 2.1 | 1.1 | 0.7 | 1.9 | 1.8 |
| Interest | 0.8 | 1.0 | 0.7 | 1.0 | 1.8 | 0.7 | 0.8 | 1.0 | 1.3 | 1.0 |
| Depreciation | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | 1.2 | 1.2 |
| Profit before tax | 7.5 | 0.2 | 12.6 | 11.2 | 20.5 | 5.5 | 8.7 | 9.8 | 11.8 | 4.6 |
| Tax % | -26.5% | -32% | -15.3% | -23.7% | -25.5% | -23% | -24.5% | 24.6% | -26.5% | 23.6% |
| Net Profit | 5.5 | 0.2 | 10.7 | 8.5 | 15.3 | 4.2 | 6.6 | 7.4 | 8.6 | 3.5 |
| EPS in Rs | 1.14 | 0.03 | 2.2 | 1.76 | 3.17 | 0.87 | 1.37 | 1.53 | 0 | 0.73 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 158.0 | 148.9 | 117.0 | 152.6 | 158.9 | 186.1 | 139.4 | 151.6 | 166.2 | 172.4 |
| Expenses | 145.7 | 136.7 | 108.4 | 129.8 | 135.3 | 164.4 | 121.3 | 136.8 | 146.4 | 155.3 |
| Operating Profit | 12.3 | 12.2 | 8.6 | 22.8 | 23.6 | 21.7 | 18.2 | 14.7 | 19.8 | 17.1 |
| OPM % | 7.8% | 8.17% | 7.39% | 14.96% | 14.84% | 11.66% | 13.03% | 9.72% | 11.93% | 9.92% |
| Other Income | 2.2 | 3.8 | 0.1 | 0.1 | 2.4 | 9.7 | 2.6 | 1.0 | 0.2 | 3.3 |
| Interest | 2.2 | 1.8 | 1.8 | 1.9 | 2.2 | 2.6 | 2.2 | 2.2 | 2.2 | 2.8 |
| Depreciation | 3.2 | 3.2 | 3.3 | 2.8 | 3.3 | 3.6 | 3.9 | 3.9 | 4.0 | 3.9 |
| Profit before tax | 9.1 | 10.9 | 3.6 | 18.3 | 20.5 | 25.2 | 14.7 | 9.6 | 13.9 | 13.7 |
| Tax % | -24% | -26.4% | -23.2% | -24.6% | -23% | 26% | 24.7% | -23.4% | -25% | -29.2% |
| Net Profit | 6.9 | 8.0 | 2.8 | 13.8 | 15.8 | 18.6 | 11.1 | 7.4 | 10.4 | 9.7 |
| EPS in Rs | 1.44 | 1.67 | 0.58 | 2.85 | 3.27 | 3.85 | 2.3 | 1.53 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 9% |
| 3 Years: | 10% |
| TTM: | -20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 19% |
| 3 Years: | 32% |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 47% |
| 3 Years: | -6% |
| 1 Year: | -20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 12% |
| 3 Years: | -14% |
| TTM: | -24% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 47% |
| 3 Years: | -6% |
| 1 Year: | -20% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|